Published in Clin Exp Immunol on August 01, 1991
Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol (1992) 1.08
Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect Immun (1995) 1.05
Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood. Nat Protoc (2013) 0.97
Joining chain-expressing and -nonexpressing B cell populations in the mouse. J Exp Med (2001) 0.84
Membrane isoforms of human immunoglobulins of the A1 and A2 isotypes: structural and functional study. Immunology (1997) 0.81
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 2.20
An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages. J Immunol Methods (1982) 2.06
Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest (1983) 1.86
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
Tissue origins of human polymeric and monomeric IgA. J Immunol (1982) 1.73
Two types of IgA immunocytes in man. Nat New Biol (1973) 1.65
Studies on human intestinal immunoglobulin A. Gastroenterology (1971) 1.62
The coming of age of the immunoglobulin J chain. Annu Rev Immunol (1985) 1.59
IgA subclasses. Monogr Allergy (1986) 1.57
Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J Exp Med (1980) 1.44
Studies on J chain and binding site for secretory component in circulating human B cells. Clin Exp Immunol (1976) 1.42
Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods (1986) 1.32
Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines. J Exp Med (1977) 1.25
Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections. J Clin Microbiol (1985) 1.22
Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J Immunol (1989) 1.16
The origin of monomeric and polymeric forms of IgA in man. Adv Exp Med Biol (1974) 1.11
Secretory component: interactions with intracellular and surface immunoglobulins of human lymphoid cells. J Immunol (1979) 1.09
Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution. J Immunol (1988) 1.06
Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology (1988) 1.06
Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol (1987) 1.05
J chain in malignant human IgG immunocytes. Scand J Immunol (1975) 1.02
Synthesis, assembly, and secretion of globulin by mouse myeloma cells. IV. Assembly of IgA. J Immunol (1972) 1.02
Synthesis and secretion of IgA, IgM, and IgG by peripheral blood mononuclear cells in human disease states, by isolated human intestinal mononuclear cells, and by human bone marrow mononuclear cells from ribs. Ann N Y Acad Sci (1983) 0.99
In vitro regulation of IgA subclass synthesis. I. Discordance between plasma cell production and antibody secretion. J Exp Med (1982) 0.96
Polymeric and monomeric IgA response in serum and milk after parenteral cholera and oral typhoid vaccination. Scand J Immunol (1988) 0.95
The synthesis and assembly of immunoglobulins by malignant human plasmacytes. 3. Heterogeneity in IgA polymer assembly. Eur J Immunol (1974) 0.92
Biosynthesis of J-chain in human lymphoid cells producing immunoglobulins of various isotypes. Mol Immunol (1983) 0.91
Immunoglobulin a biosynthesis. Intracellular accumulation of 7 S subunits. FEBS Lett (1971) 0.87
Immunoglobulin A antibody against hepatitis B core antigen of polymeric and monomeric forms, as well as of IgA1 and IgA2 subclasses, in acute and chronic infection with hepatitis B virus. Hepatology (1986) 0.86
Cellular origins of human polymeric and monomeric IgA: intracellular and secreted forms of IgA. J Immunol (1984) 0.85
Immunoglobulin A (IgA) polymerization sites in human immunocytes: immunoelectron microscopic study. Cell Struct Funct (1990) 0.77
Transcription, translation and secretion of both IgA subclasses in polyclonally activated human lymphocytes. Eur J Immunol (1990) 0.77
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65
The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol (1987) 5.30
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
The mucosal immune system: from fundamental concepts to vaccine development. Vaccine (1992) 3.99
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 3.53
Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med (1989) 3.28
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum (1976) 2.97
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med (2001) 2.87
Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science (1976) 2.78
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest (1999) 2.77
Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 2.64
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol (1979) 2.60
Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun (1979) 2.57
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol (1981) 2.54
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses. J Immunol (1978) 2.28
Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins. J Exp Med (1978) 2.26
IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies. J Immunol (1980) 2.23
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 2.20
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine (1995) 2.06
An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages. J Immunol Methods (1982) 2.06
Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science (1971) 2.03
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med (1988) 2.02
Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis (1993) 1.98
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95
Immunoglobulin A (IgA). Methods Enzymol (1985) 1.94
Accessory cells in murine Peyer's patch. I. Identification and enrichment of a functional dendritic cell. J Exp Med (1983) 1.92
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain (1999) 1.91
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods (1988) 1.91
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun (1976) 1.85
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release (2001) 1.85
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med (1998) 1.83
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol (1990) 1.82
Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol (1988) 1.80
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol (1989) 1.76
Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer (1985) 1.74
Murine model for evaluation of protective immunity to influenza virus. Vaccine (1993) 1.73
Tissue origins of human polymeric and monomeric IgA. J Immunol (1982) 1.73
Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol (1994) 1.72
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun (1996) 1.71
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and the joint fluids of patients with rheumatoid arthritis. Immunochemistry (1976) 1.67
The human IgA system: a reassessment. Clin Immunol Immunopathol (1986) 1.64
Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol (1993) 1.64
Prevention of MIF activity by agents known to increase cellular cyclic AMP. J Immunol (1973) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology (1999) 1.63
Studies on human secretory immunoglobulin A. II. Subunit structure. J Immunol (1972) 1.62
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum (1990) 1.61
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis (2000) 1.61
Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J Immunol (1999) 1.60
Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun (1990) 1.60
IgA subclasses. Monogr Allergy (1986) 1.57
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum (1998) 1.55
A murine model of human myeloma bone disease. Bone (1997) 1.53
Immunoglobulin A subclass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun (1985) 1.53
Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin Exp Immunol (1996) 1.51
Role of serum IgA. Hepatobiliary transport of circulating antigen. J Exp Med (1981) 1.49
Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse. Clin Exp Immunol (1978) 1.48
Development of clinical criteria for osteoarthritis. J Rheumatol (1987) 1.46
Concept of the local and common mucosal immune response. Adv Exp Med Biol (1978) 1.46
Cyclic adenosine 3',5'-monophosphate in human lung. Biochim Biophys Acta (1971) 1.44
Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J Exp Med (1980) 1.44
Biodegradable microspheres: vaccine delivery system for oral immunization. Curr Top Microbiol Immunol (1989) 1.44
Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol (1975) 1.41
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease. Blood (1999) 1.40
Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol (1988) 1.39
In vivo immune response to a T-cell-dependent antigen by cultures of disassociated murine Peyer's patch. Proc Natl Acad Sci U S A (1982) 1.39
Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses (1998) 1.38
Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun (1998) 1.36
Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol (1988) 1.36
Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect Immun (1999) 1.36